First Stage Investor

Portfolio Update: 20/20 GeneSystems Rakes in Awards, Makes Key Taiwan Deal

Portfolio Update: 20/20 GeneSystems Rakes in Awards, Makes Key Taiwan Deal
By Andy Gordon
Date May 31, 2018
Share
We recommended 20/20 GeneSystems to you exactly two weeks before Christmas last year. I considered it my special holiday gift to you, calling it “the best thing to happen to the cancer treatment space in years.” As a quick reminder, let me tell you why. Get Early Investing into your…
Early Investing

First Stage Investor

Sign up to view this First Stage Investor article

Become a smarter investor! Discover new investment opportunities and get the latest market research, trends and analysis in startups, crypto and cannabis.

Sign up today

Top Posts on Early Investing

New Pick: A Crypto With a Proven Vision

This month’s crypto recommendation is highly unusual — at least for us. Today I’m recommending a coin that’s already part of the Crypto Asset Strategies

Startup Insider: All About Options With Jeff Bishop

We love talking about startups at Early Investing. But we rarely talk about a different type of investing: options. And if there’s one person who knows options, it’s…

Behind the Pick: A RAD Crypto for Your Portfolio

Radicle — the latest addition to the Crypto Asset Strategies portfolio — is a unique recommendation for us. It’s run by a decentralized autonomous…